Article
A case report of donor cell-derived hematologic neoplasms 9 years after allogeneic hematopoietic cell transplantation.
Oncotarget - 5 Feb 2025
Mroczkowska-Bękarciak Aleksandra, Wróbel Tomasz
Abstract excerpt
BACKGROUND: The treatment of blood cancers has been revolutionized by hematopoietic stem cell transplantation. Owing to this method, we are able to effectively treat most blood cancers. However, in some cases, one of the greatest problems is the risk of relapse. Most often, relapse of the disease manifests itself as cancer cells with the same characteristics as the primary cancer. Nevertheless, a very small...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
